Skip to main content

Advertisement

SpringerLink
Log in

Glucocorticoid Induced Osteoblast Apoptosis by Increasing E4BP4 Expression via Up-regulation of Bim

  • Original Research
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Abstract

It is well known that glucocorticoid (GC)-induced bone loss is caused primarily by hypofunction and apoptosis of osteoblasts. However, the precise molecular events underlying the effect of GC on osteoblast apoptosis are not fully understood. Recent studies implicated an important role of E4BP4 in the regulation of osteoblast apoptosis and differentiation. Furthermore, E4BP4 is a GC-regulated gene required for GC-induced apoptosis in many cells. Therefore, we hypothesize that E4BP4 may be implicated in the process of GC-induced osteoblast apoptosis. Western blot, reverse-transcription-PCR, flow cytometry, and Hoechst 33258 staining were employed to investigate the role of E4BP4 in dexamethasone (DEX)-induced osteoblast apoptosis. We found that the expression of E4BP4 is significantly up-regulated in osteoblasts exposed to DEX. Furthermore, the depletion of E4BP4 significantly decreased DEX-induced osteoblast apoptosis. In addition, E4BP4 plays a crucial role in GC-evoked apoptosis of osteoblasts by enabling induction of Bim. On the basis of these results above, we can draw the conclusion that E4BP4 may contribute to the process of DEX-induced osteoblast apoptosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Kim HJ, Zhao H, Kitaura H, Bhattacharyya S, Brewer JA, Muglia LJ, Ross FP, Teitelbaum SL (2006) Glucocorticoids suppress bone formation via the osteoclast. J Clin Investig 116:2152–2160

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  2. Osella G, Ventura M, Ardito A, Allasino B, Termine A, Saba L, Vitetta R, Terzolo M, Angeli A (2012) Cortisol secretion, bone health, and bone loss: a cross-sectional and prospective study in normal non-osteoporotic women in the early postmenopausal period. Eur J Endocrinol 166:855–860

    Article  CAS  PubMed  Google Scholar 

  3. Khan YK, Kalaaji AN, Clarke BL (2008) Glucocorticoid-induced osteoporosis in dermatologic practice: a review. J Drugs Dermatol 7:1053–1059

    PubMed  Google Scholar 

  4. van Staa TP (2006) The pathogenesis, epidemiology and management of glucocorticoid-induced osteoporosis. Calcif Tissue Int 79:129–137

    Article  CAS  PubMed  Google Scholar 

  5. Usui M, Yoshida Y, Tsuji K, Oikawa K, Miyazono K, Ishikawa I, Yamamoto T, Nifuji A, Noda M (2004) Tob deficiency superenhances osteoblastic activity after ovariectomy to block estrogen deficiency-induced osteoporosis. Proc Natl Acad Sci USA 101:6653–6658

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  6. Martin-Millan M, Almeida M, Ambrogini E, Han L, Zhao H, Weinstein RS, Jilka RL, O’Brien CA, Manolagas SC (2010) The estrogen receptor-alpha in osteoclasts mediates the protective effects of estrogens on cancellous but not cortical bone. Mol Endocrinol 24:323–334

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  7. Horsch K, de Wet H, Schuurmans MM, Allie-Reid F, Cato AC, Cunningham J, Burrin JM, Hough FS, Hulley PA (2007) Mitogen-activated protein kinase phosphatase 1/dual specificity phosphatase 1 mediates glucocorticoid inhibition of osteoblast proliferation. Mol Endocrinol 21:2929–2940

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. Porter RM, Huckle WR, Goldstein AS (2003) Effect of dexamethasone withdrawal on osteoblastic differentiation of bone marrow stromal cells. J Cell Biochem 90:13–22

    Article  CAS  PubMed  Google Scholar 

  9. Conradie MM, de Wet H, Kotze DD, Burrin JM, Hough FS, Hulley PA (2007) Vanadate prevents glucocorticoid-induced apoptosis of osteoblasts in vitro and osteocytes in vivo. J Endocrinol 195:229–240

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  10. Weinstein RS (2001) Glucocorticoid-induced osteoporosis. Rev Endocr Metab Disord 2:65–73

    Article  CAS  PubMed  Google Scholar 

  11. Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC (1998) Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Investig 102:274–282

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  12. Ozkurt IC, Pirih FQ, Tetradis S (2004) Parathyroid hormone induces E4bp4 messenger ribonucleic acid expression primarily through cyclic adenosine 3′,5′-monophosphate signaling in osteoblasts. Endocrinology 145:3696–3703

    Article  CAS  PubMed  Google Scholar 

  13. Ozkurt IC, Tetradis S (2003) Parathyroid hormone-induced E4BP4/NFIL3 down-regulates transcription in osteoblasts. J Biol Chem 278:26803–26809

    Article  CAS  PubMed  Google Scholar 

  14. Cowell IG (2002) E4BP4/NFIL3, a PAR-related bZIP factor with many roles. BioEssays 24:1023–1029

    Article  CAS  PubMed  Google Scholar 

  15. Silvestris F, Cafforio P, De Matteo M, Calvani N, Frassanito MA, Dammacco F (2008) Negative regulation of the osteoblast function in multiple myeloma through the repressor gene E4BP4 activated by malignant plasma cells. Clin Cancer Res 14:6081–6091

    Article  CAS  PubMed  Google Scholar 

  16. Male V, Nisoli I, Gascoyne DM, Brady HJ (2012) E4BP4: an unexpected player in the immune response. Trends Immunol 33:98–102

    Article  CAS  PubMed  Google Scholar 

  17. Beach JA, Nary LJ, Hirakawa Y, Holland E, Hovanessian R, Medh RD (2011) E4BP4 facilitates glucocorticoid-evoked apoptosis of human leukemic CEM cells via upregulation of Bim. J Mol Signal 6:13

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  18. Gohel A, McCarthy MB, Gronowicz G (1999) Estrogen prevents glucocorticoid-induced apoptosis in osteoblasts in vivo and in vitro. Endocrinology 140:5339–5347

    CAS  PubMed  Google Scholar 

  19. Bakker AD, Klein-Nulend J (2012) Osteoblast isolation from murine calvaria and long bones. Methods Mol Biol 816:19–29

    Article  CAS  PubMed  Google Scholar 

  20. Guo L, Xu J, Qi J, Zhang L, Wang J, Liang J, Qian N, Zhou H, Wei L, Deng L (2013) MicroRNA-17-92a upregulation by estrogen leads to Bim targeting and inhibition of osteoblast apoptosis. J Cell Sci 126:978–988

    Article  CAS  PubMed  Google Scholar 

  21. Dong J, Cui X, Jiang Z, Sun J (2013) MicroRNA-23a modulates tumor necrosis factor-alpha-induced osteoblasts apoptosis by directly targeting Fas. J Cell Biochem 114:2738–2745

    Google Scholar 

  22. Walsh S, Jordan GR, Jefferiss C, Stewart K, Beresford JN (2001) High concentrations of dexamethasone suppress the proliferation but not the differentiation or further maturation of human osteoblast precursors in vitro: relevance to glucocorticoid-induced osteoporosis. Rheumatology (Oxf) 40:74–83

    Article  CAS  Google Scholar 

  23. Tong X, Muchnik M, Chen Z, Patel M, Wu N, Joshi S, Rui L, Lazar MA, Yin L (2010) Transcriptional repressor E4-binding protein 4 (E4BP4) regulates metabolic hormone fibroblast growth factor 21 (FGF21) during circadian cycles and feeding. J Biol Chem 285:36401–36409

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  24. Wallace AD, Wheeler TT, Young DA (1997) Inducibility of E4BP4 suggests a novel mechanism of negative gene regulation by glucocorticoids. Biochem Biophys Res Commun 232:403–406

    Article  CAS  PubMed  Google Scholar 

  25. Marani M, Tenev T, Hancock D, Downward J, Lemoine NR (2002) Identification of novel isoforms of the BH3 domain protein Bim which directly activate Bax to trigger apoptosis. Mol Cell Biol 22:3577–3589

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  26. Espina B, Liang M, Russell RG, Hulley PA (2008) Regulation of Bim in glucocorticoid-mediated osteoblast apoptosis. J Cell Physiol 215:488–496

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  27. Liang M, Russell G, Hulley PA (2008) Bim, Bak, and Bax regulate osteoblast survival. J Bone Miner Res 23:610–620

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  28. Cowell IG, Skinner A, Hurst HC (1992) Transcriptional repression by a novel member of the bZIP family of transcription factors. Mol Cell Biol 12:3070–3077

    CAS  PubMed Central  PubMed  Google Scholar 

  29. Benito A, Gutierrez O, Pipaon C, Real PJ, Gachon F, Ritchie AE, Fernandez-Luna JL (2006) A novel role for proline- and acid-rich basic region leucine zipper (PAR bZIP) proteins in the transcriptional regulation of a BH3-only proapoptotic gene. J Biol Chem 281:38351–38357

    Article  CAS  PubMed  Google Scholar 

  30. Ritchie A, Gutierrez O, Fernandez-Luna JL (2009) PAR bZIP-bik is a novel transcriptional pathway that mediates oxidative stress-induced apoptosis in fibroblasts. Cell Death Differ 16:838–846

    Article  CAS  PubMed  Google Scholar 

  31. Falkenstein E, Tillmann HC, Christ M, Feuring M, Wehling M (2000) Multiple actions of steroid hormones—a focus on rapid, nongenomic effects. Pharmacol Rev 52:513–556

    CAS  PubMed  Google Scholar 

  32. Thompson EB (2008) Stepping stones in the path of glucocorticoid-driven apoptosis of lymphoid cells. Acta Biochim Biophys Sin (Shanghai) 40:595–600

    Article  CAS  Google Scholar 

  33. Webb MS, Miller AL, Johnson BH, Fofanov Y, Li T, Wood TG, Thompson EB (2003) Gene networks in glucocorticoid-evoked apoptosis of leukemic cells. J Steroid Biochem Mol Biol 85:183–193

    Article  CAS  PubMed  Google Scholar 

  34. Thompson EB, Johnson BH (2003) Regulation of a distinctive set of genes in glucocorticoid-evoked apoptosis in CEM human lymphoid cells. Recent Prog Horm Res 58:175–197

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors thank Dong Jun, PhD, for advice and discussion. Supported in part by the National Natural Science Foundation of China (Grant numbers 81271236).

Author information

Authors and Affiliations

  1. Department of Orthopaedic Surgery, Shanghai Changzheng Hospital, Second Military Medical University, 415 Fengyang Road, Shanghai, 200003, China

    Fangjing Chen, Yueping OuYang, Huapeng Guan, Qi Liu & Bin Ni

  2. Department of Cardiology, Children’s Hospital of Shanghai, Shanghai Jiao Tong University, Shanghai, China

    Li Zhang

Authors
  1. Fangjing Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Li Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yueping OuYang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Huapeng Guan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Qi Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Bin Ni
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bin Ni.

Additional information

Fangjing Chen and Li Zhang have contributed equally to this article.

F. Chen, L. Zhang, Y. Ouyang, H. Guan, Q. Liu and B. Ni declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chen, F., Zhang, L., OuYang, Y. et al. Glucocorticoid Induced Osteoblast Apoptosis by Increasing E4BP4 Expression via Up-regulation of Bim. Calcif Tissue Int 94, 640–647 (2014). https://doi.org/10.1007/s00223-014-9847-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00223-014-9847-6

Keywords

Search

Navigation